Civic AI
Procurement intelligence
Federal contract award
TO DETERMINE THE ANTIVIRAL INHIBITORY EFFECT USING ASSAYS SUCH AS CPE TO DETERMINE EC50; ASSAYS SUCH AS VYR/PR TO DETERMINE EC90, AND CYTOTOXICITY (CC50) OF EXPERIMENTAL COMPOUNDS AGAINST VIRUSES THAT REQUIRE A MAXIMUM BIOSAFETY LABORATORY CONTAINMEN
UTAH STATE UNIVERSITY · Department of Health and Human Services
- Value
- $418,905
- Start
- Jan 9, 2026
- End
- Jan 8, 2027
- Action date
- Jan 7, 2026
- PIID
- 75N93026F00001
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- LOGAN, UT
- Award type
- DELIVERY ORDER
Description
TO DETERMINE THE ANTIVIRAL INHIBITORY EFFECT USING ASSAYS SUCH AS CPE TO DETERMINE EC50; ASSAYS SUCH AS VYR/PR TO DETERMINE EC90, AND CYTOTOXICITY (CC50) OF EXPERIMENTAL COMPOUNDS AGAINST VIRUSES THAT REQUIRE A MAXIMUM BIOSAFETY LABORATORY CONTAINMEN
Need modifications, related awards, and vendor peers? Open the full award workspace.